Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
for
HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma,
Location: Durham NC, The Bronx NY, San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06774027
Recruiting
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
for
Hematopoietic Stem Cell Transplant
Location: Durham NC, Tampa FL, Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 18+
Code: NCT06328127
Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: Durham NC, Charlottesville VA, Myrtle Beach SC,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase 2, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Durham NC, Greenville SC, Richmond VA, Norfolk VA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Durham NC, Fairfax VA, Washington D.C. DC,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models
for
Cancer, Predictive Cancer Model, Effects of Chemotherapy
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Known Medicine, Inc.
Sex: All
Age: 18+
Code: NCT05338073
Recruiting
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
for
Ovarian Cancer, Advanced Ovarian Carcinoma,
Location: Durham NC, Boston MA, Aurora CO, Boulder CO
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 18+
Code: NCT06710548
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Winston-Salem NC, Beckley WV, Columbia SC,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Durham NC, Chesapeake VA, Fairfax VA, Atlanta GA,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase 2, Recruiting
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
for
Brain Tumor, Primary, Brain Metastases, Adult
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT05480644
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: Durham NC, Morrisville NC, Roanoke VA, Asheville NC,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase 3, Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Location: Durham NC, Richmond VA, Atlanta GA, Columbus OH,
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT03567889
Phase 3, Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy